Erlotinib Hydrochloride contains not less than 98.0% and not more than 102.0% of C22H24ClN3O4, calculated on the dried basis.

共有 1 個藥物證書使用此成份

鹽酸厄洛替尼
Erlotinib Hydrochloride

• 申請商: 丞泰企業有限公司
• 適應症: 抗癌藥物
• 發證日期: 2020-05-11